InnoCan Pharma Corporation IP4.F Stock
InnoCan Pharma Corporation Price Chart
InnoCan Pharma Corporation IP4.F Financial and Trading Overview
| InnoCan Pharma Corporation stock price | 0.2 EUR |
| Previous Close | 0.17 EUR |
| Open | 0.2 EUR |
| Bid | 0.18 EUR x N/A |
| Ask | 0.2 EUR x N/A |
| Day's Range | 0.2 - 0.2 EUR |
| 52 Week Range | 0.1 - 0.45 EUR |
| Volume | 700 EUR |
| Avg. Volume | 11.92K EUR |
| Market Cap | 53.62M EUR |
| Beta (5Y Monthly) | 3.505608 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IP4.F Valuation Measures
| Enterprise Value | 38.57M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.895497 |
| Price/Book (mrq) | 9.081819 |
| Enterprise Value/Revenue | 9.994 |
| Enterprise Value/EBITDA | -6.785 |
Trading Information
InnoCan Pharma Corporation Stock Price History
| Beta (5Y Monthly) | 3.505608 |
| 52-Week Change | -57.97% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.45 EUR |
| 52 Week Low | 0.1 EUR |
| 50-Day Moving Average | 0.17 EUR |
| 200-Day Moving Average | 0.21 EUR |
IP4.F Share Statistics
| Avg. Volume (3 month) | 11.92K EUR |
| Avg. Daily Volume (10-Days) | 4.37K EUR |
| Shares Outstanding | 251.81M |
| Float | 225.63M |
| Short Ratio | N/A |
| % Held by Insiders | 28.43% |
| % Held by Institutions | 0.21% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -113.57% |
| Operating Margin (ttm) | -148.044% |
| Gross Margin | 88.07% |
| EBITDA Margin | -147.29% |
Management Effectiveness
| Return on Assets (ttm) | -40.38% |
| Return on Equity (ttm) | -62.31% |
Income Statement
| Revenue (ttm) | 3.86M EUR |
| Revenue Per Share (ttm) | 0.02 EUR |
| Quarterly Revenue Growth (yoy) | 500.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | -5684000 EUR |
| Net Income Avi to Common (ttm) | -4383000 EUR |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.09M EUR |
| Total Cash Per Share (mrq) | 0.02 EUR |
| Total Debt (mrq) | 26K EUR |
| Total Debt/Equity (mrq) | 0.49 EUR |
| Current Ratio (mrq) | 6.057 |
| Book Value Per Share (mrq) | 0.022 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5651000 EUR |
| Levered Free Cash Flow (ttm) | -4956875 EUR |
Profile of InnoCan Pharma Corporation
| Country | Germany |
| State | AB |
| City | Calgary |
| Address | 1015, 926 – 5 Avenue SW |
| ZIP | T2P 0N7 |
| Phone | 403-777-1519 |
| Website | https://innocanpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
InnoCan Pharma Corporation, a pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally. It engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes to pain relief and treatment of epilepsy and other central nervous system disorders and other indications. The company offers its products under the Shir and Relief & Go brand names. It is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The company was incorporated in 2018 and is headquartered in Calgary, Canada.
Q&A For InnoCan Pharma Corporation Stock
What is a current IP4.F stock price?
InnoCan Pharma Corporation IP4.F stock price today per share is 0.2 EUR.
How to purchase InnoCan Pharma Corporation stock?
You can buy IP4.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for InnoCan Pharma Corporation?
The stock symbol or ticker of InnoCan Pharma Corporation is IP4.F.
Which industry does the InnoCan Pharma Corporation company belong to?
The InnoCan Pharma Corporation industry is Drug Manufacturers-Specialty & Generic.
How many shares does InnoCan Pharma Corporation have in circulation?
The max supply of InnoCan Pharma Corporation shares is 280.66M.
What is InnoCan Pharma Corporation Price to Earnings Ratio (PE Ratio)?
InnoCan Pharma Corporation PE Ratio is now.
What was InnoCan Pharma Corporation earnings per share over the trailing 12 months (TTM)?
InnoCan Pharma Corporation EPS is -0.02 EUR over the trailing 12 months.
Which sector does the InnoCan Pharma Corporation company belong to?
The InnoCan Pharma Corporation sector is Healthcare.